Microbot Medical (Microbot Medical) Beneish M-Score

: 0.00 (As of Today)

View and export this data going back to 1992. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Microbot Medical's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Microbot Medical was -0.11. The lowest was -0.11. And the median was -0.11.

Microbot Medical Beneish M-Score Historical Data

The historical data trend for Microbot Medical's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

Microbot Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beneish M-Score	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbot Medical Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Beneish M-Score falls into.

Microbot Medical Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Microbot Medical for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Dec23) TTM:

Last Year (Dec22) TTM:

Total Receivables was $1.49 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $7.92 Mil.
Total Assets was $8.33 Mil.
Property, Plant and Equipment(Net PPE) was $0.41 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.11 Mil.
Selling, General, & Admin. Expense(SGA) was $4.32 Mil.
Total Current Liabilities was $3.79 Mil.
Long-Term Debt & Capital Lease Obligation was $0.04 Mil.
Net Income was -3.154 + -2.446 + -2.287 + -2.853 = $-10.74 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -1.821 + -1.655 + -1.854 + -3.203 = $-8.53 Mil.

Total Receivables was $0.53 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $8.81 Mil.
Total Assets was $9.54 Mil.
Property, Plant and Equipment(Net PPE) was $0.72 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.10 Mil.
Selling, General, & Admin. Expense(SGA) was $5.58 Mil.
Total Current Liabilities was $2.07 Mil.
Long-Term Debt & Capital Lease Obligation was $0.18 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(1.487 / 0)	/	(0.532 / 0)
	=		/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (7.921 + 0.406) / 8.327)	/	(1 - (8.814 + 0.723) / 9.537)
	=	0	/	0
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.102 / (0.102 + 0.723))	/	(0.106 / (0.106 + 0.406))
	=	0.123636	/	0.207031
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(4.317 / 0)	/	(5.581 / 0)
	=		/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.04 + 3.786) / 8.327)	/	((0.179 + 2.069) / 9.537)
	=	0.459469	/	0.235714
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-10.74 - 0	-	-8.533)	/	8.327
	=	-0.265041

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Microbot Medical Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Microbot Medical's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbot Medical (Microbot Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (NAS:MBOT) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

CY9D:Germany

Address

25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043

Website

https://microbotmedical.com

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Executives

Rachel Vaknin	officer: Chief Financial Officer	DROR 3/10, ZICHRON YAAKOV L3 3090216
Simon Sharon	officer: General Manager & CTO	8 HAMADA STREET, ZICHRON YAACOV L3 3090708
Yoseph Bornstein	director, 10 percent owner	16 IRUS STREET, ROSH HA'AYIN L3 4858022
Tal Baruch Wenderow	director	1149, BEACON STREET, NEWTON MA 02461
Eyal Morag	officer: Chief Medical Officer	BONEY HAEAR 3 STREET, APT #13, TEL AVIV L3 6937303
Aileen Ptucha Stockburger	director	26 WELLINGTON CT, BELLE MEADE NJ 08502
Harel Gadot	director, 10 percent owner, officer: Chairman and CEO	5 VILLAGE LANE, HINGHAM MA 02043
Joseph Mona	10 percent owner	808 HAMPTON ST, COLUMBIA SC 29201
Prattipati Laxminarain	director	3 HEWINS FARM ROAD, WELLESLEY MA 02481
Yoav Zvi Waizer	director	8 HAVERED STREET, RAANANA L3 4352308
Moshe Shoham	director	22 BEDOLACH STREET, HOSHAYA L3 1791500
Leon Lewkowicz	10 percent owner	GORDON STREET 10, APARTMENT 7, TEL-AVIV L3 63458
Martin J. Madden	director	C/O MICROBOT MEDICAL INC., 175 DERBY STREET 27/1, HINGHAM MA 02043
Yehezkel Himelfarb	officer: General Manager & COO	32 BEN YOSEF STREET, TEL-AVIV L3 6912530
Sandra Berkson	10 percent owner	C/O SABER HOLDING GMBH, WEIN KRUMMBAUMGASSE C4 1020